Clinical Trial: Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519330) titled 'Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection' on April 02.

Brief Summary: Study HH006-202 is designed to assesses the efficacy and safety of HH-006 in adults chronic HBV infection. Eligible participants will receive study treatment for 48 weeks. All treated patients will also undergo a follow-up period after last study drug treatment.

Study Start Date: April 29

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B Virus Infection

Intervention: BIOLOGICAL: HH-006

HH-006 480 mg SC injection every one week for 4 weeks and followed by 240 mg QW for 44 weeks...